Quantitative PCR analysis of c-erb B-2 (HER2/neu) gene amplification and comparison with p185HER2/neu protein expression in breast cancer drill biopsies
Open Access
- 8 October 1999
- journal article
- clinical trial
- Published by Wiley in International Journal of Cancer
- Vol. 83 (2) , 157-161
Abstract
A PCR assay using capillary electrophoresis was designed for the detection of c‐erbB‐2 gene amplification in alcohol‐formalin‐acetic acid (AFA)–fixed, paraffin‐embedded biopsies from 81 consecutive breast tumors. c‐erbB‐2 expression was analyzed in the same samples using immuno‐histochemistry (IHC). In the competitive PCR assay, a single pTag plasmid containing a 4‐nucleotide (nt)‐deleted copy of a 124‐nt sequence of c‐erbB‐2 and a 4‐nt‐deleted copy of a 120‐nt sequence of GAPDH was co‐amplified with genomic DNA extracted from 3 10‐μm‐thick tissue sections of the tumor biopsy. The percentage of tumor cells in the biopsy specimen and the percentage of tumor cells stained with the membrane anti‐c‐erbB‐2 monoclonal antibody CB11 were recorded by a single pathologist on 2 consecutive sections. Among 81 consecutive tumor biopsies assayed by PCR, 21 (26%) displayed unequivocal c‐erbB‐2 amplification (actual gene copy number, AGCN > 4), 47 (58%) displayed no c‐erbB‐2 amplification (AGCN ≤ 2) and 7 (9%) could not be analyzed due to an insufficient amount of DNA. Six samples (7%) were considered inconclusive since the percentage of tumor cells was erbB‐2 gene amplification can be accurately quantitated by competitive PCR performed on small, fixed and embedded tumor samples. Int. J. Cancer 83:157–161, 1999.Keywords
This publication has 21 references indexed in Scilit:
- Should Selection of Adjuvant Chemotherapy for Patients With Breast Cancer Be Based on erbB-2 Status?JNCI: Journal of the National Cancer Institute, 1998
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.Journal of Clinical Oncology, 1998
- neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.Journal of Clinical Oncology, 1998
- Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.Journal of Clinical Oncology, 1997
- Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapyBritish Journal of Cancer, 1995
- Determination of Gene Dosage by a Quantitative Adaptation of the Polymerase Chain Reaction (gd-PCR): Rapid Detection of Deletions and Duplications of Gene SequencesGenomics, 1994
- Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization.Proceedings of the National Academy of Sciences, 1994
- Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.Journal of Clinical Oncology, 1992
- HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.Journal of Clinical Oncology, 1992
- Absolute mRNA quantification using the polymerase chain reaction (PCR). A novel approach by aPCR aidedtranscipttitration assay (PATTY)Nucleic Acids Research, 1989